The National Pancreatic Cancer Roadmap will guide evidence-based research and best practice care to improve outcomes for people affected by pancreatic cancer.
Welcome to the National Pancreatic Cancer Roadmap
This webpage provides information, news and updates about the development of a National Pancreatic Cancer Roadmap. You will also be able to find out more about how you can provide your input into this initiative.
On 23 March 2020, the Minister for Health, the Hon. Greg Hunt MP, invited Cancer Australia to work with the Department of Health to develop a National Pancreatic Cancer Roadmap (the Roadmap) to support improved outcomes and survival for people with pancreatic cancer.
Pancreatic cancer is anticipated to be the third leading cause of cancer death in Australia in 2020, and its five-year relative survival has only increased from 3.2% to 10.7 % over the last 30 years. The announcement recognises the impact of pancreatic cancer and the opportunity to improve outcomes.
Cancer Australia is adopting an evidence-based approach to develop the National Pancreatic Cancer Roadmap, underpinned by a consultative process. A National Pancreatic Cancer Roadmap webpage has been established as an information and engagement centre for the duration of this initiative.
Why is a Roadmap being developed?
The National Pancreatic Cancer Roadmap will identify key priority areas for action over the next five years across the continuum of pancreatic cancer care and pancreatic cancer research, to improve outcomes and survival for people with pancreatic cancer.
The Roadmap is anticipated to be relevant to, and be used by, a range of pancreatic cancer stakeholders including governments, researchers, health professionals, funders, pancreatic cancer organisations and people affected by pancreatic cancer.
How will the Roadmap be developed?
The Roadmap will be informed by an analysis of the current status of pancreatic cancer research, treatment and care in Australia and will be aligned with the Optimal care pathway for people with pancreatic cancer.
Principles will underpin the development of the Roadmap and guide the identification of priority areas for action.
When will the Roadmap be developed?
The Roadmap is expected to be developed by December 2021.
How will Cancer Australia engage with its stakeholders?
Cancer Australia will collaborate with key stakeholders, including consumers, and build on the efforts and expertise of the non-government sector in the development of the Roadmap.
Key stakeholders include the Australian community, people affected by pancreatic cancer, health professionals, clinical colleges, researchers and research institutes, cancer organisations, peak bodies and government (all jurisdictions and representative bodies, such as the National Cancer Expert Reference Group).
Engaging collaboratively with a range of population groups, including Aboriginal and Torres Strait Islander Peoples, rural and remote communities, and culturally and linguistically diverse groups will be a key focus of engagement.
If you would like an interpreter to help you understand this information, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.
Have your say
Cancer Australia undertook broad public consultation with key stakeholders and interested peak bodies, groups and individuals from September 2020 – November 2020. The public consultation through the dedicated consultation hub is now closed. Cancer Australia would like to thank those who have taken the time to provide a response for this important initiative.
Cancer Australia has established a dedicated National Pancreatic Cancer Roadmap email inbox if you want to contact us directly on: PancreaticCancerRoadmap@canceraustralia.gov.au